virus stock Moderna

Moderna CEO Dumping Thousands of Shares

Moderna's Stephane Bancel Dumping Stocks Regularly

Moderna’s CEO Stephane Bancel has been regularly  dropping thousands of shares of his company’s stock prior to the much anticipated trial data for Moderna’s COVID-19 vaccine trial candidate, mRNA-1273. How confident can he be in the long-term situation for his company? Does he think his company is overvalued? He’s filed numerous Form-4 document with the Securities and Exchange Commission. There are so many that it’s impossible to ignore them.